Metabolic Health Across Menopause — Why Stage-Specific Care Matters

Menopause is not a single event — it’s a staged hormonal transition that affects metabolic health differently at each phase. Yet most women receive the same generic advice regardless of where they actually are in that transition.

A 2026 study published in Endocrine Practice examined metabolic differences across 718 women at pre-, peri- and post-menopausal stages, finding that metabolic characteristics and lifestyle risk factors differed meaningfully between groups — and that each stage carries its own distinct set of priorities.

Key findings included that premenopausal women showed more negative metabolic markers including higher BMI and waist circumference alongside poorer dietary patterns and higher stress levels — suggesting that metabolic risk begins well before the menopausal transition itself. Perimenopausal women showed improvements in some markers but postmenopausal women had the highest systolic blood pressure and HbA1c levels, pointing to increasing cardiovascular and glycaemic risk as oestrogen declines further.

The authors concluded that targeted, stage-specific interventions are needed across the menopausal transition — with premenopausal women benefiting from early metabolic risk management, and peri- and postmenopausal women prioritising physical activity and glycaemic control.

This is precisely the framework behind our Perimenopause & Menopause Support Program. Rather than a one-size approach, we assess where you are in your hormonal transition, what your biomarkers are showing at that stage, and build a care plan that reflects the metabolic priorities specific to you.

Source: Nguyen et al., Endocrine Practice, 2026.
Read the full study here